BenchSci

BenchSci’s vision is to bring novel medicine to patients 50% faster by 2025. To achieve this, they're exponentially increasing the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence. Backed by F-Prime, Gradient Ventures (Google’s AI fund), Inovia Capital, and TCV, their platform accelerates science at 16 of the top-20 pharmaceutical companies, and over 4,300 leading research centers worldwide. They're a remote-first company recognized for their impact and culture as a Deloitte Tech Fast 50TM, CIX Top 10 Growth, Great Place to Work®, and top-ranked organization on Glassdoor.